Jade Biosciences, Inc.

8-K Entered a material agreement Jul 1, 2026 8-K Director or officer change; Regulation FD disclosure Jun 26, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 11, 2026 8-K Other events Jun 4, 2026 8-K Regulation FD disclosure; Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 22, 2026 8-K Director or officer change Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 6, 2026 8-K Results of operations (earnings release) Mar 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 5, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release); Other events Nov 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 7, 2025 8-K Director or officer change Sep 9, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Jul 1, 2025 8-K Completed an acquisition or disposition; Results of operations (earnings release); Regulation FD disclosure May 14, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure May 1, 2025 8-K Regulation FD disclosure Apr 29, 2025 10-Q Quarter ended 2025-03-31 Apr 25, 2025 8-K Other events Apr 23, 2025 8-K Shareholder vote results; Regulation FD disclosure; Other events Apr 21, 2025 8-K Regulation FD disclosure; Other events Apr 9, 2025 8-K Other events Apr 9, 2025 8-K Regulation FD disclosure; Other events Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Oct 31, 2024 8-K Delisting notice or listing-rule failure Oct 17, 2024 8-K Director or officer change Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Other events Jul 8, 2024 8-K/A Exit or disposal costs Jul 1, 2024 8-K Exit or disposal costs Jun 28, 2024 8-K Regulation FD disclosure; Other events Jun 17, 2024 8-K Shareholder vote results Jun 7, 2024